Specialty Pharma Journal Specialty, Precision & Technology
HAMBURG, Germany–(BUSINESS WIRE)–Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that Evotec and Celgene Corporation (“Celgene”) have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology. Evotec has built one of the industry’s broadest and most innovative pre-clinical discovery and …
Tag Archives: Evotec
May, 2018
October, 2017
-
27 October
Evotec and Tesaro Partner to Discover Novel Immuno-Oncology Agents
HAMBURG, Germany–(BUSINESS WIRE)–Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and TESARO, Inc. (“TESARO”) today announced a three-year integrated drug discovery collaboration to discover and develop novel small molecule product candidates against an undisclosed immuno-oncology (IO) target. Under the terms of the collaboration, Evotec will apply its integrated drug …
December, 2016
-
16 December
Celgene and Evotec Partner for Development of Drugs for Neurodegenerative Diseases
HAMBURG, Germany–(BUSINESS WIRE)–* Exclusive broad R&D collaboration based on Evotec’s unique induced pluripotent stem cell (“iPSC”) platform which enables systematic drug screening in patient-derived disease models Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that Evotec and Celgene Corporation have entered into a strategic drug discovery and …
March, 2015
-
23 March
Sanofi and Evotec Sign Long-Term Drug Discovery Deal
Sanofi has signed a multi-component strategic agreement with Evotec over the next five years. The companies announced a definitive agreement for a major multi-component strategic alliance, successfully concluding the exclusive negotiations for a major multi-component strategic collaboration which the two companies entered into on December 2, 2014. The transaction, which …